One of the largest but least-well-known of the few woman-owned hedge fund firms is the latest life sciences specialist to see big rewards from the red-hot IPO market. Cormorant Asset Management, headed by Bihua Chen, owns nearly 1.5 million shares of BioAtla, which surged more than
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.